Annual General Meeting 2022: Tecan shareholders approve significant dividend increase

Votes cast exclusively through the independent proxy in line with COVID-19 Ordinance 3 of the Swiss government to combat the pandemic Increase in the dividend from CHF 2.30 to CHF 2.80 per share Myra Eskes elected as new member of the Board of Directors Lukas Braunschweiler, Heinrich Fischer, Oliver Fetzer, Karen Huebscher, Christa Kreuzburg and Daniel R. Marshak re-elected as members of [...]

NanoString Technologies Announces Preliminary Revenue for First Quarter of Fiscal Year 2022

SEATTLE -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced preliminary total product and service revenue of approximately $31 million for the first quarter. This unaudited estimate, based on management's preliminary financial analysis, is lower than the company's previous guidance for product and service revenue [...]

REITHERA AND EXOTHERA COLLABORATE TO DEVELOP LARGE-SCALE, LOW COST PER DOSE MANUFACTURING PROCESS TO DELIVER NOVEL VACCINES TO LOW- AND MIDDLE- INCOME COUNTRIES

ReiThera and Exothera Collaborate to Develop Large-scale, Low Cost per Dose Manufacturing Process to Deliver Novel Vaccines to Low- and Middle- Income Countries Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation Focus on developing a scale-up manufacturing process for the production of ReiThera’s vaccine candidates based on its GRAd platform, including [...]

Osaka University, Shimadzu, and SIGMAXYZ Collaborate on 3D Bioprinting Technology ~Accelerating technological development to solve social issues such as the environment, food, and health~

National University Corporation Osaka University ("Osaka University"), Shimadzu Corporation ("Shimadzu"), and SIGMAXYZ Inc. ("SIGMAXYZ") have signed an agreement on collaboration for "social implementation of 3D bioprinting technology." Prior to this, Osaka University and Shimadzu Corporation also signed a joint research agreement on the development of automated production equipment for tailor-made cultured meat using 3D bioprinting. [...]

CliniSys acquires ApolloLIMS to grow community and public health diagnostics capability

Acquisition confirms CliniSys Group as a market leader in public health and toxicology diagnostics in North America; provides springboard for global growth TUCSON, Arizona – CliniSys today announced it has acquired ApolloLIMS, a leading provider of laboratory information management systems based in Nashville, Tennessee, and with specialist expertise in clinical, public health, toxicology and molecular diagnostics. The ApolloLIMS team will join CliniSys, bringing [...]

BC Platforms Partners with SAS to Deliver Faster Insights from Patient Data for Global Health Care and Life Sciences

BC Platforms (BCP), a global leader in health care data management and analytics, today announced a partnership with analytics leader SAS to support customers in health care and life sciences. SAS’ powerful analytics for health care and life sciences, combined with the repeatable, modular and ease-of-use data management capabilities of BC Platforms, will provide swift and controlled access [...]

BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY

MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) and Cygnus Technologies, part of Maravai LifeSciences (NASDAQ: MRVI), announced today the launch of the Simple Plex™ HEK 293 HCP 3G assay for automated process impurity testing on the Ella™ immunoassay platform. Purification of viral particles to minimize host cell protein (HCP) contaminants is a crucial aspect of the [...]

INFICON: Oliver Wyrsch, Head of the US Business of INFICON, succeeds Lukas Winkler in the position as CEO on January 1, 2023

Bad Ragaz/Switzerland -- The Board of Directors of INFICON Holding AG announces that Oliver Wyrsch (1977), President and General Manager of the US Business at INFICON, will succeed Lukas Winkler as Chief Executive Officer (CEO) of INFICON Holding AG. Based on its long-term and deliberate succession planning, INFICON can appoint an internal candidate for the [...]

Illumina Expands Access to Genomics in Latin America through New State-of-the-Art Solution Center

Regional Solution Center in São Paulo, Brazil will enable customer access to next-generation sequencing training and expertise to improve patient outcomes  SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of its new state-of-the-art Solution Center in São Paulo, Brazil. The choice to bring the facility to [...]

DNA Script Launches Early Access Program for Latest Advancements to the SYNTAX Platform and Enzymatic DNA Synthesis Technology

Program participants receive early access to the upcoming release of kits designed to print longer oligos and enable labeling with fluorophores, quenchers, and biotin. SOUTH SAN FRANCISCO, Calif., and PARIS -- DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, announced the launch of a new program for customers of [...]

Access IBO on Knowledge Center